Bermel RA - Search Results

1

Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.

Bermel RA, Fedler JK, Kaiser P, Novalis C, Schneebaum J, Klingner EA, Williams D, Yankey JW, Ecklund DJ, Chase M, Naismith RT, Klawiter EC, Goodman AD, Coffey CS, Fox RJ. Bermel RA, et al. Mult Scler. 2021 Aug;27(9):1384-1390. doi: 10.1177/1352458520964409. Epub 2020 Oct 15. Mult Scler. 2021. PMID: 33054533 Free PMC article. Clinical Trial.

2

Interferon-beta treatment for multiple sclerosis.

Bermel RA, Rudick RA. Bermel RA, et al. Neurotherapeutics. 2007 Oct;4(4):633-46. doi: 10.1016/j.nurt.2007.07.001. Neurotherapeutics. 2007. PMID: 17920544 Free PMC article. Review.

3

Picturing injury and recovery with diffusion tensor imaging: the eyes have it.

Bermel RA, Fox RJ. Bermel RA, et al. Neurology. 2009 Feb 17;72(7):584-5. doi: 10.1212/01.wnl.0000336559.52816.16. Epub 2008 Dec 10. Neurology. 2009. PMID: 19073946 No abstract available.

4

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.

Bermel RA, Weinstock-Guttman B, Bourdette D, Foulds P, You X, Rudick RA. Bermel RA, et al. Mult Scler. 2010 May;16(5):588-96. doi: 10.1177/1352458509360549. Epub 2010 Feb 18. Mult Scler. 2010. PMID: 20167591 Clinical Trial.

5

Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy.

Bermel RA, Rae-Grant AD, Fox RJ. Bermel RA, et al. Mult Scler. 2010 Nov;16(11):1335-40. doi: 10.1177/1352458510377334. Epub 2010 Jul 29. Mult Scler. 2010. PMID: 20670982

6

Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.

Ontaneda D, LaRocca N, Coetzee T, Rudick R; NMSS MSFC Task Force. Ontaneda D, et al. Mult Scler. 2012 Aug;18(8):1074-80. doi: 10.1177/1352458512451512. Epub 2012 Jun 27. Mult Scler. 2012. PMID: 22740488

7

MRI in multiple sclerosis.

Bermel RA, Fox RJ. Bermel RA, et al. Continuum (Minneap Minn). 2010 Oct;16(5 Multiple Sclerosis):37-57. doi: 10.1212/01.CON.0000389933.77036.14. Continuum (Minneap Minn). 2010. PMID: 22810597

8

Optic neuritis and the evaluation of visual impairment in multiple sclerosis.

Bermel RA, Balcer LJ. Bermel RA, et al. Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):1074-86. doi: 10.1212/01.CON.0000433282.00221.7e. Continuum (Minneap Minn). 2013. PMID: 23917102 Review.

9

Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.

Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A; ADVANCE Study Investigators. Calabresi PA, et al. Lancet Neurol. 2014 Jul;13(7):657-65. doi: 10.1016/S1474-4422(14)70068-7. Epub 2014 Apr 30. Lancet Neurol. 2014. PMID: 24794721 Clinical Trial.

10

Using MRI to make informed clinical decisions in multiple sclerosis care.

Bermel RA, Naismith RT. Bermel RA, et al. Curr Opin Neurol. 2015 Jun;28(3):244-9. doi: 10.1097/WCO.0000000000000204. Curr Opin Neurol. 2015. PMID: 25887772 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page